Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Citi
Chinese Patent Office
Chubb
UBS
Accenture

Generated: August 17, 2019

DrugPatentWatch Database Preview

Litigation Details for BAXTER HEALTHCARE CORPORATION v. HQ SPECIALTY PHARMA CORPORATION (D.N.J. 2013)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

BAXTER HEALTHCARE CORPORATION v. HQ SPECIALTY PHARMA CORPORATION (D.N.J. 2013)

Docket   Try a Free Trial Date Filed 2013-10-18
Court District Court, D. New Jersey Date Terminated 2016-02-22
Cause 35:271 Patent Infringement Assigned To Jerome B. Simandle
Jury Demand Defendant Referred To Magistrate Judge Karen M. Will
Parties BAXTER HEALTHCARE CORPORATION; BAXTER HEALTHCARE S.A.; BAXTER INTERNATIONAL INC.; ESTATE OF GEORGE OWOO; HQ SPECIALTY PHARMA CORPORATION; MS. JANET FENNING-OWOO; WELGRACE RESEARCH GROUP
Patents 6,310,094; 6,528,540; 8,829,054; 8,835,505
Attorneys ARNOLD B. CALMANN; BRIAN M. GOLDBERG; CLIFFORD MARC DAVIDSON; EDWARD J. DAUBER; JEFFREY S. SOOS; KATHERINE ANN ESCANLAR; ROBERT D. RHOAD; TERI-LYNN ALLONARDO EVANS; THOMAS P. LIHAN; VINCENT AUGUST GALLO
Firms Davidson Davidson & Kappel LLC; Dechert LLP; Law Office of Thomas Lihan LLC; Teri-Lynn Allonardo Evans; Vincent August Gallo
Link to Docket External link to docket
Small Molecule Drugs cited in BAXTER HEALTHCARE CORPORATION v. HQ SPECIALTY PHARMA CORPORATION
The small molecule drugs covered by the patents cited in this case are   Try a Free Trial and   Try a Free Trial .

Details for BAXTER HEALTHCARE CORPORATION v. HQ SPECIALTY PHARMA CORPORATION (D.N.J. 2013)

Date Filed Document No. Description Snippet Link To Document
2015-09-23 201 manufacture patents for Baxter’s esmolol hydrochloride product, U.S. Patent Nos. 6,310,094 (hereinafter… “’094 Patent”) and 6,528,540 (hereinafter, “’540 Patent” and collectively, the “patents-in-suit… (’094 Patent at 1:64-65; ’540 Patent at 2:5-6.) Indeed, the ’094 Patent states that …equivalent of the ’094 Patent, E.U. Patent No. EP 1 368 019 B1 (hereinafter, “EP 1 Patent”),18 Dr. of…disclosures of the EP 1 Patent with the patents-in-suit reveals that the patents are substantially, if External link to document
2016-01-26 259 .S. Patent Nos. 6,310,094 (hereinafter, “’094 Patent”) and 6,528,540 (hereinafter, “’540 Patent” and… 8607 patents 15 presently at issue. 16 (See generally ’094 Patent; ’540 Patent.) 15 …the named inventors on Baxter’s Patents. 3 1 The esmolol patents asserted by Baxter issued in 2001…and collectively, “Baxter’s Patents”). Taken together, these patents teach a ready-to-use, injectable…in a sealed container. (See ’094 Patent at 5:8-6:23; ’540 Patent at 5:60- 8:11.) 2 The infringement External link to document
2014-06-20 52 Attachments: # 1 Exhibit A - U.S. Patent No. 6,310,094, # 2 Exhibit B - U.S. Patent No. 6,528,540, # 3 Exhibit… 22 February 2016 1:13-cv-06228-JBS-KMW Patent Defendant District Court, D. External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Citi
Healthtrust
QuintilesIMS
Cantor Fitzgerald
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.